Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-004475-12Phase 2Completed
Phase 2, open-label, single-arm trial of oxaliplatin and capecitabine in rectal adenocarcinoma, sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Primary endpoint: Pathological response rate. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-004475-12.